We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

MTD Study of Vaccine BP-GMAX-CD1 Plus AP1903 to Treat Castrate Resistant Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00868595
Recruitment Status : Completed
First Posted : March 25, 2009
Last Update Posted : October 8, 2019
M.D. Anderson Cancer Center
The University of Texas Health Science Center, Houston
Memorial Hermann Hospital
Baylor College of Medicine
Information provided by (Responsible Party):
Bellicum Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 2011
Actual Study Completion Date : March 2012